2023
DOI: 10.3390/cells12071031
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS

Abstract: Amyotrophic lateral sclerosis (ALS) is a clinical diagnosis used to define a neurodegenerative process that involves progressive loss of voluntary muscle function and leads to death within 2–5 years after diagnosis, in most cases because of respiratory function failure. Respiratory vital capacity (VC) measurements are reproducible and strong predictors of survival. To understand the role of the innate immune response in progressive VC loss we evaluated ALS clinical trial and biomarker results from a 6-month ph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…This is further associated increased abundance of C3 and the receptor for its C3a cleavage product (C3AR1) near ALS motor neurons ( Woodruff et al, 2008 ; Heurich et al, 2011 ; Bahia El Idrissi et al, 2016 ), which can indirectly enhance neutrophil recruitment via their effect on other immune cells ( Daffern et al, 1995 ; Warwick et al, 2021 ). These results underscore a nexus of innate immune cells and immunomodulatory proteins in ALS, bolstering the rationale for development of drug candidates targeting innate immune pathways ( Miller R. G. et al, 2022 ; Zhang R. et al, 2022 ; McGrath et al, 2023 ).…”
Section: Discussionmentioning
confidence: 67%
“…This is further associated increased abundance of C3 and the receptor for its C3a cleavage product (C3AR1) near ALS motor neurons ( Woodruff et al, 2008 ; Heurich et al, 2011 ; Bahia El Idrissi et al, 2016 ), which can indirectly enhance neutrophil recruitment via their effect on other immune cells ( Daffern et al, 1995 ; Warwick et al, 2021 ). These results underscore a nexus of innate immune cells and immunomodulatory proteins in ALS, bolstering the rationale for development of drug candidates targeting innate immune pathways ( Miller R. G. et al, 2022 ; Zhang R. et al, 2022 ; McGrath et al, 2023 ).…”
Section: Discussionmentioning
confidence: 67%